Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Evgen Pharma ( (GB:TCF) ) is now available.
TheraCryf PLC, a company involved in the pharmaceutical industry, has reported a change in its major holdings. Simon Gibeon, based in London, has acquired a significant portion of voting rights, totaling 3.3527% of the company’s shares. This acquisition could potentially influence the company’s future decisions and strategic direction, impacting stakeholders and market dynamics.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
Find detailed analytics on TCF stock on TipRanks’ Stock Analysis page.